DEXCOM INC — Director's Dealing 2021

May 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2021-05-21

Reporting Person: Dahut Karen M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-21	Common Stock	A	918	$0.001	Acquired	2078	Direct

Footnotes

F1: The RSU Award was granted on May 21, 2021 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.

F2: Included in this number are 2,078 unvested restricted stock units, 918 of which were granted on May 21, 2021 and shall vest on the earlier of the one year anniversary of the grant or the date of DexCom Inc's 2022 Annual Meeting and 1,160 of which were granted on August 11, 2020 and shall vest through August 11, 2023.